Although preliminary, findings of this study indicate that FCR is highly prevalent in women who have had breast cancer and are carriers of a BRCA1/2 genetic mutation, even after undergoing preventive surgery, procedures that are known to significantly reduce the risk of recurrence. This evidence concerns the gene BRCA1 and breast carcinoma.